|
1
|
Devaney K, Snyder R, Norris HJ and
Tavassoli FA: Proliferative and histologically malignant struma
ovarii: A clinicopathologic study of 54 cases. Int J Gynecol
Pathol. 12:333–343. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Outwater EK, Siegelman ES and Hunt JL:
Ovarian teratomas: Tumor types and imaging characteristics.
Radiographics. 21:475–490. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hanby A and Walker C: Pathology and
genetics: Tumours of the breast and female genital organs. WHO
classification of tumours series-volume IV. Lyon, France: IARC
Press. Breast Cancer Res. 6:1332004. View
Article : Google Scholar
|
|
4
|
Goffredo P, Sawka AM, Pura J, Adam MA,
Roman SA and Sosa JA: Malignant struma ovarii: A population-level
analysis of a large series of 68 patients. Thyroid. 25:211–215.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li S, Yang T, Xiang Y, Li X, Zhang L and
Deng S: Clinical characteristics and survival outcomes of malignant
struma ovarii confined to the ovary. BMC Cancer. 21:3832021.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Yang T, Li X, Zhang L, Shi H, Cheng
N and Lang J: FIGO stage IV and age over 55 years as prognostic
predicators in patients with metastatic malignant struma ovarii.
Front Oncol. 10:5849172020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shrimali RK, Shaikh G and Reed NS:
Malignant struma ovarii: The west of Scotland experience and review
of literature with focus on postoperative management. J Med Imaging
Radiat Oncol. 56:478–482. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shaco-Levy R, Peng RY, Snyder MJ, Osmond
GW, Veras E, Bean SM, Bentley RC and Robboy SJ: Malignant struma
ovarii: A blinded study of 86 cases assessing which histologic
features correlate with aggressive clinical behavior. Arch Pathol
Lab Med. 136:172–178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li S, Kong S, Wang X, Zhang X, Yin M and
Yang J: Survival outcomes and prognostic predictors in patients
with malignant struma ovarii. Front Med (Lausanne). 8:7746912021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tessler FN, Middleton WD, Grant EG, Hoang
JK, Berland LL, Teefey SA, Cronan JJ, Beland MD, Desser TS, Frates
MC, et al: ACR thyroid imaging, reporting and data system
(TI-RADS): White paper of the ACR TI-RADS committee. J Am Coll
Radiol. 14:587–595. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dardik RB, Dardik M, Westra W and Montz
FJ: Malignant struma ovarii: Two case reports and a review of the
literature. Gynecol Oncol. 73:447–451. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Janszen EW, van Doorn HC, Ewing PC, de
Krijger RR, de Wilt JH, Kam BL and de Herder WW: Malignant struma
ovarii: Good response after thyroidectomy and I ablation therapy.
Clin Med Oncol. 2:147–152. 2008.PubMed/NCBI
|
|
14
|
Marti JL, Clark VE, Harper H, Chhieng DC,
Sosa JA and Roman SA: Optimal surgical management of
well-differentiated thyroid cancer arising in struma ovarii: A
series of 4 patients and a review of 53 reported cases. Thyroid.
22:400–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leite I, Cunha TM, Figueiredo JP and Félix
A: Papillary carcinoma arising in struma ovarii versus ovarian
metastasis from primary thyroid carcinoma: A case report and review
of the literature. J Radiol Case Rep. 7:24–33. 2013.PubMed/NCBI
|
|
16
|
Krishnamurthy A, Ramshankar V,
Vaidyalingam V and Majhi U: Synchronous papillary carcinoma thyroid
with malignant struma ovarii: A management dilemma. Indian J Nucl
Med. 28:243–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leong A, Roche PJ, Paliouras M, Rochon L,
Trifiro M and Tamilia M: Coexistence of malignant struma ovarii and
cervical papillary thyroid carcinoma. J Clin Endocrinol Metab.
98:4599–4605. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brusca N, Del Duca SC, Salvatori R,
D'Agostini A, Cannas P, Santaguida MG, Virili C, Bianchi L, Gargano
L and Centanni M: A case report of thyroid carcinoma confined to
ovary and concurrently occult in the thyroid: Is conservative
treatment always advised? Int J Endocrinol Metab.
13:e182202015.PubMed/NCBI
|
|
19
|
Ma D, Guseva NV, Dahmoush L and Robinson
RA: Struma ovarii with malignant transformation and germline KIT
mutation: A case report with review of the literature. Int J
Gynecol Pathol. 35:442–447. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Middelbeek RJW, O'Neill BT, Nishino M and
Pallotta JA: Concurrent intrathyroidal thyroid cancer and thyroid
cancer in struma ovarii: A case report and literature review. J
Endocr Soc. 1:396–400. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gomes-Lima CJ, Nikiforov YE, Lee W and
Burman KD: Synchronous independent papillary thyroid carcinomas in
struma ovarii and the thyroid gland with different RAS mutations. J
Endocr Soc. 2:944–948. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tzelepis EG, Barengolts E, Garzon S,
Shulan J and Eisenberg Y: Unusual case of malignant struma ovarii
and cervical thyroid cancer preceded by ovarian teratoma: Case
report and review of the literature. Case Rep Endocrinol.
2019:79641262019.PubMed/NCBI
|
|
23
|
Donato S, Simões H and Leite V: Malignant
struma ovarii with concurrent thyroid cancer: Outcomes during and
after pregnancy. Eur Thyroid J. 10:523–527. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seo GT, Minkowitz J, Kapustin DA, Fan J,
Minkowitz G, Minkowitz M, Dowling E, Matloob A, Asti D, Dhar M, et
al: Synchronous thyroid cancer and malignant struma ovarii:
Concordant mutations and microRNA profile, discordant loss of
heterozygosity loci. Diagn Pathol. 18:472023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boyd JC, Williams BA, Rigby MH, Kieser K,
Offman S, Shirsat H, Trites JRB, Taylor SM and Hart RD: Malignant
Struma ovarii in a 30-year old nulliparous patient. Thyroid Res.
10:32017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lim ST, Jeong HJ, Chung MJ, Yim CY and
Sohn MH: Malignant struma ovarii demonstrated on post-therapy
radioiodine scan after total thyroidectomy for papillary thyroid
cancer. Clin Nucl Med. 33:429–431. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kitahara CM and Sosa JA: The changing
incidence of thyroid cancer. Nat Rev Endocrinol. 12:646–653. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Poli R, Scatolini M, Grosso E, Maletta F,
Gallo M, Liscia D, Nelva A, Cesario F, Forte G, Metovic J, et al:
Malignant struma ovarii: Next-generation sequencing of six cases
revealed Nras, Braf, and Jak3 mutations. Endocrine. 71:216–224.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moon S, Song YS, Kim YA, Lim JA, Cho SW,
Moon JH, Hahn S, Park DJ and Park YJ: Effects of coexistent BRAF
V600E and TERT promoter mutations on poor clinical
outcomes in papillary thyroid cancer: A meta-analysis. Thyroid.
27:651–660. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Siegel MR, Wolsky RJ, Alvarez EA and
Mengesha BM: Struma ovarii with atypical features and synchronous
primary thyroid cancer: A case report and review of the literature.
Arch Gynecol Obstet. 300:1693–1707. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ayhan S, Kilic F, Ersak B, Aytekin O, Akar
S, Turkmen O, Akgul G, Toyran A, Turan T and Kimyon Comert G:
Malignant struma ovarii: From case to analysis. J Obstet Gynaecol
Res. 47:3339–3351. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Filetti S, Durante C, Hartl D, Leboulleux
S, Locati LD, Newbold K, Papotti MG, Berruti A, ESMO Guidelines
Committee and Electronic address: simpleclinicalguidelines@esmo.org:
Thyroid cancer: ESMO clinical practice guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 30:1856–1883. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yassa L, Sadow P and Marqusee E: Malignant
struma ovarii. Nat Clin Pract Endocrinol Metab. 4:469–472. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Prat J: FIGO's staging classification for
cancer of the ovary, fallopian tube, and peritoneum: abridged
republication. J Gynecol Oncol. 26:87–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
